Select Medical (NYSE:SEM) Lowered to Hold Rating by StockNews.com

StockNews.com cut shares of Select Medical (NYSE:SEM) from a buy rating to a hold rating in a research note published on Monday.

Other equities research analysts have also recently issued research reports about the company. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Royal Bank of Canada raised their price objective on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th.

Select Medical Stock Up 0.3 %

Select Medical stock opened at $18.85 on Monday. The firm has a market cap of $2.44 billion, a price-to-earnings ratio of 8.81, a PEG ratio of 0.39 and a beta of 1.43. Select Medical has a 52-week low of $18.02 and a 52-week high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The firm has a 50 day moving average price of $27.45 and a two-hundred day moving average price of $32.41.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter last year, the firm earned $0.46 earnings per share. Select Medical’s quarterly revenue was up 5.7% on a year-over-year basis. Equities analysts predict that Select Medical will post 1.97 EPS for the current year.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 2.65%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s payout ratio is 23.36%.

Insiders Place Their Bets

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the sale, the director now directly owns 22,000 shares of the company’s stock, valued at $463,980. This represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Dimensional Fund Advisors LP lifted its stake in Select Medical by 2.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock valued at $157,728,000 after acquiring an additional 95,578 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Select Medical by 2.0% in the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after purchasing an additional 46,880 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of Select Medical by 6.7% during the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after purchasing an additional 147,032 shares in the last quarter. Point72 Asset Management L.P. boosted its holdings in Select Medical by 144.2% during the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after purchasing an additional 1,216,263 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Select Medical by 1.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock worth $57,407,000 after purchasing an additional 24,439 shares in the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.